Valuation Macro Group Pharmaceuticals (Macro Capital) S.A.E

Stocks

End-of-day quote Egyptian Exchange Other stock markets 2026-07-28			5-day change	1st Jan Change
1.530 ^EGP	+2.68%		+10.87%	+34.21%

05-17	Macro Group Pharmaceutical Q1 consol profit egp 33.3 million	RE
02-19	Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2025	2026	2027	2028
Market Cap ¹	650	872.4	-	-
Change	-	34.21%	-	-
Enterprise Value (EV) ¹	650	792.7	762.4	604.4
Change	-	21.95%	-3.82%	-20.72%
P/E	5.7x	25.5x	17x	13.9x
PBR	-	9x	6.95x	5.67x
PEG	-	-0.4x	0.3x	0.6x
Capitalization / Revenue	-	0.73x	0.56x	0.45x
EV / Revenue	-	0.67x	0.49x	0.31x
EV / EBITDA	-	2.93x	2x	1.2x
EV / EBIT	-	3.39x	2.12x	1.26x
EV / FCF	-	16.8x	4.26x	1.75x
FCF Yield	-	5.94%	23.5%	57.2%
Dividend per Share ²	-	0.03	0.04	0.06
Rate of return	-	1.96%	2.61%	3.92%
EPS ²	0.2	0.06	0.09	0.11
Distribution rate	-	50%	44.4%	54.5%
Net sales ¹	-	1,190	1,552	1,946
EBITDA ¹	-	271	381	504
EBIT ¹	-	234	360	481
Net income ¹	115.7	206	283	373
Net Debt ¹	-	-79.7	-110	-268
Reference price ²	1.140	1.530	1.530	1.530
Nbr of stocks (in thousands)	570,206	570,206	-	-
Announcement Date	2/19/26	-	-	-

¹EGP in Million²EGP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MACRO GROUP PHARMACEUTICALS (MACRO CAPITAL) S.A.E	24.83x	0.65x	2.84x	-	16.75M
ELI LILLY AND COMPANY	35.56x	12.7x	26.67x	0.56%	1,068B
JOHNSON & JOHNSON	28.51x	6.52x	18.04x	2.02%	641B
ABBVIE INC.	32.33x	7.59x	15.6x	2.68%	454B
ROCHE HOLDING AG	19.49x	4.75x	11.79x	2.78%	351B
NOVARTIS AG	22.29x	5.76x	14.37x	2.78%	299B
ASTRAZENECA PLC	21.47x	4.5x	12.72x	1.93%	266B
NOVO NORDISK A/S	14.4x	5.35x	11.02x	3.48%	220B
AMGEN INC.	24.71x	6.49x	11.44x	2.68%	203B
GILEAD SCIENCES, INC.	-47.03x	5.64x	31.15x	2.53%	162B
Average	17.66x	5.99x	15.56x	2.38%	366.34B
Weighted average by Cap.	24.76x	7.96x	18.76x	1.95%